Dorbimex Antiseptic

Dorbimex

Reliable protection for healthcare personnel
Dorbimex is an effective antiseptic with a >5 log-kill rate against various pathogens by at least 100,000 times. It also provides longer protection with 48+ hours higher than chlorhexidine and other antimicrobials. Devised for use in hospitals and other medical settings, it reduces infection risk during surgery and other procedures.

• Extended Protection
• Novel Patented Antiseptic for Medical Use only
• Quick action
• Effective against key pathogens including, Staphylococcus aureus, Pseudomonas aeruginosa and Klebsiella pneumonia° (NDM -1)
• Low Toxicity/Irritancy
• Patented in 12 countries

Significant CLABSI Reduction:

Clinical trials reveal a 94% reduction in Central Line-Associated Bloodstream Infections (CLABSI), with cases dropping from an average of 48 to just 3.
Exceptional Surface Disinfection:

Dorbimex ensures over a 5-log reduction in pathogen levels, eliminating 99.999% of microorganisms and reducing viable pathogens by at least 100,000 times.
Rapid Action with Long-Lasting Protection:

Capable of killing bacteria in under 15 seconds, Dorbimex provides extended residual protection for more than 48 hours, outperforming chlorhexidine and other antimicrobials.
Comprehensive Antimicrobial Efficacy

Demonstrates robust, multimodal action against a wide range of pathogens, including viruses, yeast, fungi, and both Gram-positive and Gram-negative bacteria.
Safe and Effective Against Biofilms

Dorbimex is non-irritating, free of allergens, and specifically designed to penetrate and eradicate biofilms—an essential feature for effective infection control.